Wells Fargo & Company upgraded shares of Doximity (NYSE:DOCS – Free Report) from an equal weight rating to an overweight rating in a research note issued to investors on Tuesday, Marketbeat Ratings reports. Wells Fargo & Company currently has $55.00 price objective on the stock.
Other equities research analysts have also issued research reports about the stock. Royal Bank Of Canada raised shares of Doximity to a “moderate buy” rating in a report on Thursday, January 8th. The Goldman Sachs Group raised shares of Doximity from a “strong sell” rating to a “hold” rating in a research note on Friday, January 9th. Wall Street Zen lowered shares of Doximity from a “buy” rating to a “hold” rating in a report on Saturday, January 10th. Truist Financial raised Doximity from a “hold” rating to a “strong-buy” rating in a report on Thursday, January 8th. Finally, Barclays raised Doximity to a “strong-buy” rating in a report on Monday, December 8th. Two equities research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, Doximity currently has an average rating of “Buy” and a consensus price target of $55.00.
Check Out Our Latest Stock Report on DOCS
Doximity Trading Up 2.4%
Doximity Company Profile
Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.
The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.
Further Reading
- Five stocks we like better than Doximity
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
